Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
The annotations only declare readOnlyHint=true, so the description usefully adds scope beyond that: it discloses that pricing is subject to the published page and market qualifiers, and enumerates what data the tool does not access (account, tenant, clinical, patient, billing, etc.). These data-boundary disclosures are valuable context that the annotations do not carry.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.